Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRUS Merus B.V.

交易中 12-19 09:32:53 EST

96.89

+0.09

+0.09%

最高96.95	最低96.85	成交量5.45万
今开96.93	昨收96.80	日振幅0.10%
总市值73.49亿	流通市值63.57亿	总股本7,585万
成交额528.55万	换手率0.08%	流通股本6,561万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRUS","market":"US","secType":"STK","nameCN":"Merus B.V.","latestPrice":96.89,"timestamp":1766154759486,"preClose":96.8,"halted":0,"volume":54529,"delay":0,"floatShares":65607927,"shares":75847175,"eps":-5.361263,"marketStatus":"交易中","change":0.09,"latestTime":"12-19 09:32:53 EST","open":96.93,"high":96.95,"low":96.8513,"amount":5285498.15116,"amplitude":0.00102,"askPrice":96.9,"askSize":579,"bidPrice":96.89,"bidSize":350,"shortable":3,"etf":0,"ttmEps":-5.361263,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766178000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1463630400000,"exchange":"NASDAQ","adjPreClose":96.8,"preHourTrading":{"tag":"盘前","latestPrice":96.9,"preClose":96.8,"latestTime":"09:29 EST","volume":58190,"amount":5632998.5745,"timestamp":1766154599108},"postHourTrading":{"tag":"盘后","latestPrice":97,"preClose":96.8,"latestTime":"19:24 EST","volume":2329,"amount":225786.3618,"timestamp":1766103898141},"volumeRatio":6.757225,"impliedVol":0.2985,"impliedVolPercentile":0.196},"requestUrl":"/m/hq/s/MRUS/tweets","defaultTab":"tweets","newsList":[{"id":"1111389833","title":"Genmab完成对Merus N.V.未流通普通股的要约收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1111389833","media":"投资观察","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111389833?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:11","pubTimestamp":1765523498,"startTime":"0","endTime":"0","summary":"12月12日 - Genmab A/S宣布完成对Merus N.V.未流通普通股的要约收购，并正式开始后续要约期。Genmab预计将在2027年推出Petosemtamab，并计划扩展和加速Petosemtamab的研发，未来可能拓展至其他治疗领域。Genmab相信，Petosemtamab将在2029年前能为EBITDA带来正面贡献，并具备每年十亿美元的销售潜力。94.2%的Merus股份已在Genmab的要约中被提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","MRUS","LU0889565916.HKD","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"1106735817","title":"Leerink Partners下调Merus NV评级至\"与市场持平\" 目标价上调至97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106735817","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106735817?lang=zh_cn&edition=full","pubTime":"2025-10-06 11:15","pubTimestamp":1759720517,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners对生物技术公司Merus NV的投资评级进行了调整，将其评级从此前的\"跑赢大盘\"下调至\"与市场持平\"。尽管评级有所下调，但该机构同时上调了目标价，从95美元提升至97美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4139","MRUS"],"gpt_icon":0},{"id":"1117767726","title":"Genmab拟斥资80亿美元全现金收购Merus，每股报价97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117767726","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117767726?lang=zh_cn&edition=full","pubTime":"2025-09-29 13:21","pubTimestamp":1759123271,"startTime":"0","endTime":"0","summary":"9月29日，$Genmab(GMAB)$同意以每股97美元的全现金价格收购$Merus(MRUS)$，交易总价值约80亿美元。 美股夜盘时段，Merus大涨近20%，而Genmab则下跌近3%。","market":"us","thumbnail":"https://static.tigerbbs.com/0b841f5eda278b95023e7905323fa0be","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0b841f5eda278b95023e7905323fa0be"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"484c19b5e334de9a1873457964a50ace","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Genmab拟斥资80亿美元全现金收购Merus，每股报价97美元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRUS","BK4598","BK4550","BK4516","BK4099","BK4574","BK4604","BK4612","BK4585","BK4533","GMAB","BK4588","BK4511","BK4555","BK4581","BK4548","BK4543","BK4592","BK4527","BK4551","BK4534"],"gpt_icon":0},{"id":"2558664813","title":"Merus N.V.2025财年第二财季实现净利润-1.58亿美元，同比减少215.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558664813?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:00","pubTimestamp":1754928031,"startTime":"0","endTime":"0","summary":"8月12日，Merus N.V.公布财报，公告显示公司2025财年第二财季净利润为-1.58亿美元，同比减少215.75%；其中营业收入为8.83百万美元，同比增加20.46%，每股基本收益为-2.23美元。机构评级：截至2025年8月12日，当前有16家机构对Merus N.V.目标价做出预测，其中目标均价为91.62美元，其中最低目标价为66.00美元，最高目标价为110.00美元。Merus 只有一个可报告的业务部门，包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000057a6dfeaa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000057a6dfeaa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS"],"gpt_icon":0},{"id":"2557709823","title":"Merus N.V.盘中异动 早盘股价大跌6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557709823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557709823?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487156,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，Merus N.V.股票出现波动，股价大幅下跌6.14%。截至发稿，该股报63.31美元/股，成交量2.5553万股，换手率0.03%，振幅1.50%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.12%。Merus N.V.公司简介：Merus NV 是一家临床阶段的免疫肿瘤学公司。该公司正在开发全长人类多特异性抗体治疗药物，称为 Biclonics。Merus 只有一个可报告的业务部门，包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213236a6d6b37b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213236a6d6b37b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","MRUS"],"gpt_icon":0},{"id":"2552482374","title":"Merus N.V.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482374?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:43","pubTimestamp":1752759839,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时43分，Merus N.V.股票出现波动，股价急速拉升5.02%。截至发稿，该股报59.34美元/股，成交量9.3752万股，换手率0.13%，振幅4.19%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.29%。Merus N.V.公司简介：Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门，包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214400a45144e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214400a45144e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0320765992.SGD","MRUS","BK4139","LU0109394709.USD"],"gpt_icon":0},{"id":"2550520336","title":"Merus N.V.盘中异动 下午盘股价大涨5.24%报55.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550520336?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:15","pubTimestamp":1752081338,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时15分，Merus N.V.股票出现异动，股价急速上涨5.24%。截至发稿，该股报55.07美元/股，成交量63.3263万股，换手率0.85%，振幅4.56%。Merus N.V.股票所在的生物技术行业中，整体涨幅为1.06%。Merus N.V.公司简介：Merus NV 是一家临床阶段的免疫肿瘤学公司。Merus 只有一个可报告的业务部门，包括双特异性治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710011539953c63a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710011539953c63a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4139","MRUS"],"gpt_icon":0},{"id":"2518720878","title":"B of A Securities：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由73.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720878","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518720878?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626170,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由73.00美元调整至70.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11010248641318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRUS"],"gpt_icon":0},{"id":"1110650193","title":"Merus公司2024财年GAAP每股收益$(3.35)优于估值$(3.80)，销售额$36.133未达$38.544M估值","url":"https://stock-news.laohu8.com/highlight/detail?id=1110650193","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110650193?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692783,"startTime":"0","endTime":"0","summary":"Merus  报告季度每股亏损$，优于分析师一致预期的$，上升了11.84%。该公司报告的季度销售额为$36.133，未达到分析师一致预期的$38.544百万。以上内容来自Benzinga Earnings专栏，原文如下：Merus  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.84 percent.  The company reported quarterly sales of $36.133 which missed the analyst consensus estimate of $38.544 million by 100.00 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Merus公司2024财年GAAP每股收益$(3.35)优于估值$(3.80)，销售额$36.133未达$38.544M估值","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRUS"],"gpt_icon":0},{"id":"2514685102","title":"Merus N.V.盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514685102?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:09","pubTimestamp":1740582563,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时09分，Merus N.V.股票出现波动，股价急速上涨5.02%。截至发稿，该股报46.63美元/股，成交量10.4188万股，换手率0.15%，振幅5.11%。Merus N.V.股票所在的生物技术行业中，整体跌幅为0.06%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230923a254ffa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230923a254ffa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","LU0109394709.USD","LU0320765992.SGD","MRUS"],"gpt_icon":0},{"id":"2512360494","title":"Merus N.V.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512360494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512360494?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:59","pubTimestamp":1739995187,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时59分，Merus N.V.股票出现异动，股价快速拉升5.04%。截至发稿，该股报44.40美元/股，成交量40.5406万股，换手率0.59%，振幅5.73%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.61%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220035947988b64b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220035947988b64b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0320765992.SGD","BK4139","LU0109394709.USD","MRUS"],"gpt_icon":0},{"id":"2512164147","title":"Merus N.V.盘中异动 股价大涨5.02%报42.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512164147?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:51","pubTimestamp":1739893915,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时51分，Merus N.V.股票出现波动，股价急速上涨5.02%。截至发稿，该股报42.22美元/股，成交量19.3414万股，换手率0.28%，振幅4.15%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.83%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182351559627a645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182351559627a645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","MRUS"],"gpt_icon":0},{"id":"2511021510","title":"Merus(MRUS.US)获Piper Sandler首次覆盖，给予增持评级, 目标价84.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511021510","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511021510?lang=zh_cn&edition=full","pubTime":"2025-02-13 18:53","pubTimestamp":1739443989,"startTime":"0","endTime":"0","summary":"Merus(MRUS.US)获Piper Sandler首次覆盖，给予增持评级, 目标价84.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13185348145391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRUS"],"gpt_icon":0},{"id":"2503837585","title":"Merus N.V.盘中异动 股价大跌5.34%报41.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503837585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503837585?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778712,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Merus N.V.股票出现波动，股价快速下挫5.34%。截至发稿，该股报41.51美元/股，成交量1.1042万股，换手率0.02%，振幅0.16%。Merus N.V.股票所在的生物技术行业中，整体跌幅为1.01%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223153a2203ed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223153a2203ed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4139","MRUS","LU0109394709.USD"],"gpt_icon":0},{"id":"2502894623","title":"Merus N.V.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502894623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502894623?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:39","pubTimestamp":1736527153,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时39分，Merus N.V.股票出现波动，股价急速上涨5.09%。截至发稿，该股报44.38美元/股，成交量44.6674万股，换手率0.65%，振幅6.88%。Merus N.V.股票所在的生物技术行业中，整体跌幅为1.73%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011100391395ff87ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011100391395ff87ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","MRUS"],"gpt_icon":0},{"id":"2492159220","title":"Merus N.V.盘中异动 急速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159220?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:29","pubTimestamp":1734553795,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时29分，Merus N.V.股票出现波动，股价急速下跌5.16%。截至发稿，该股报42.58美元/股，成交量64.5614万股，换手率0.94%，振幅5.62%。机构评级方面，在所有18家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Merus N.V.股票所在的生物技术行业中，整体跌幅为2.43%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042955ab829bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042955ab829bca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","MRUS","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2492990414","title":"Merus N.V.盘中异动 股价大涨5.02%报44.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492990414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492990414?lang=zh_cn&edition=full","pubTime":"2024-12-18 04:49","pubTimestamp":1734468576,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日04时49分，Merus N.V.股票出现异动，股价急速拉升5.02%。截至发稿，该股报44.95美元/股，成交量66.7878万股，换手率0.98%，振幅5.14%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.76%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218044936ab7ff4c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218044936ab7ff4c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","MRUS","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2490773514","title":"Merus N.V.盘中异动 股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773514?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:31","pubTimestamp":1733754673,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时31分，Merus N.V.股票出现波动，股价急速下跌5.40%。截至发稿，该股报42.24美元/股，成交量2.2832万股，换手率0.03%，振幅0.41%。机构评级方面，在所有17家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.19%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223114ab6a0942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223114ab6a0942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRUS","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2489418841","title":"Merus N.V.盘中异动 临近收盘股价大跌5.05%报43.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489418841","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489418841?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:35","pubTimestamp":1733430902,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时35分，Merus N.V.股票出现异动，股价急速下跌5.05%。截至发稿，该股报43.19美元/股，成交量37.0409万股，换手率0.54%，振幅8.14%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.17%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206043502a1d73d2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206043502a1d73d2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0889565916.HKD","MRUS","LU0320765992.SGD"],"gpt_icon":0},{"id":"2488718672","title":"Merus N.V.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488718672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488718672?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:39","pubTimestamp":1733150398,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时39分，Merus N.V.股票出现波动，股价快速上涨5.52%。截至发稿，该股报47.32美元/股，成交量4.185万股，换手率0.06%，振幅3.01%。Merus N.V.股票所在的生物技术行业中，整体跌幅为0.05%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222395998e4ebc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222395998e4ebc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merus.nl","stockEarnings":[{"period":"1week","weight":0.0018},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.4189},{"period":"6month","weight":0.8228},{"period":"1year","weight":1.2809},{"period":"ytd","weight":1.302}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Merus N.V.是在荷兰法律下成立于2003年6月16日。该公司是一个临床阶段的免疫肿瘤学公司开发创新的双特异性抗体治疗。其全长人双特异性抗体的候选人的管道，他们将其称为biclonics，从他们技术平台产生。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.093783},{"month":2,"riseRate":0.555556,"avgChangeRate":0.063295},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.034321},{"month":4,"riseRate":0.555556,"avgChangeRate":0.005312},{"month":5,"riseRate":0.555556,"avgChangeRate":0.022377},{"month":6,"riseRate":0.6,"avgChangeRate":0.06743},{"month":7,"riseRate":0.5,"avgChangeRate":0.029651},{"month":8,"riseRate":0.2,"avgChangeRate":-0.0088},{"month":9,"riseRate":0.5,"avgChangeRate":0.138868},{"month":10,"riseRate":0.5,"avgChangeRate":-0.032973},{"month":11,"riseRate":0.5,"avgChangeRate":0.006855},{"month":12,"riseRate":0.8,"avgChangeRate":0.07873}],"exchange":"NASDAQ","name":"Merus B.V.","nameEN":"Merus NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Merus B.V.(MRUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Merus B.V.,MRUS,Merus B.V.股票,Merus B.V.股票老虎,Merus B.V.股票老虎国际,Merus B.V.行情,Merus B.V.股票行情,Merus B.V.股价,Merus B.V.股市,Merus B.V.股票价格,Merus B.V.股票交易,Merus B.V.股票购买,Merus B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Merus B.V.(MRUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}